Literature DB >> 20190597

The safety and efficacy of benzodiazepine-modified treatments as a special form of unmodified ECT.

Nilesh Shah1, Sarika Mahadeshwar, Savita Bhakta, Mahesh Bhirud, Praveen Fernandes, Chittaranjan Andrade.   

Abstract

BACKGROUND: Muscle relaxants reduce musculoskeletal morbidity with electroconvulsive therapy (ECT) but need to be administered under general anesthesia. The administration of anesthesia is not always possible for patients prescribed ECT. Consequently, unmodified ECT is still widely practiced, especially in developing countries.
METHODS: We prospectively assessed musculoskeletal morbidity in consecutive patients who received unmodified bitemporal ECT during a part or the whole of their ECT course. All patients were pretreated with an intravenous benzodiazepine (usually diazepam, 10 mg) to effect sedation, anxiolysis, and limited skeletal muscle relaxation. Anteroposterior and lateral digital x-rays of the thoracolumbar spine were obtained after the last unmodified treatment.
RESULTS: Fifty-six patients aged 11 to 49 years and with a mean body mass index of 23.0 received a total of 162 (mean, 2.9) unmodified ECTs. There was significant attenuation of psychopathology ratings. Against our expectations, no patient developed clinical or radiological evidence of orthopedic morbidity; however, in 2 patients, the x-rays revealed old spinal fractures. Twelve patients had spots of oral bleeding after ECT. Whereas 5 patients experienced mild, transient, self-limiting postictal confusion, only one had confusion which required medical termination. Five patients complained of body ache and one of memory impairment. There were no other adverse events.
CONCLUSIONS: The complete absence of orthopedic morbidity with benzodiazepine-modified ECT contrasts with historical descriptions of a 20% to 40% risk with unmodified ECT. We speculate that the limited muscle relaxant action of the pre-ECT parenteral benzodiazepine may have had protective effects. If so, if ECT is urgently indicated but anesthesia and hence conventional muscle relaxants cannot be administered, benzodiazepine-modified ECT may be a safer alternative to unmodified ECT. This suggestion merits wide attention because of its public health importance in countries with poor medical infrastructure, where unmodified ECT is still widely practiced.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20190597     DOI: 10.1097/YCT.0b013e3181d2711f

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  6 in total

1.  Position statement and guidelines on unmodified electroconvulsive therapy.

Authors:  Chittaranjan Andrade; N Shah; P Tharyan; M S Reddy; M Thirunavukarasu; R A Kallivayalil; R Nagpal; N K Bohra; A Sharma; E Mohandas
Journal:  Indian J Psychiatry       Date:  2012-04       Impact factor: 1.759

2.  How to write a good abstract for a scientific paper or conference presentation.

Authors:  Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2011-04       Impact factor: 1.759

3.  Electro-convulsive Therapy: A Few Lingering Thoughts/Doubts!

Authors:  M S Reddy
Journal:  Indian J Psychol Med       Date:  2011-07

4.  Unmodified electroconvulsive therapy: Concerns about reporting in a retrospective study.

Authors:  Chittaranjan Andrade; Samir Kumar Praharaj; Nachiketa Desai; Devavrat Harshe; Sagar Karia
Journal:  Indian J Psychiatry       Date:  2017 Jan-Mar       Impact factor: 1.759

5.  Molecular mechanisms underlying electroconvulsive therapy-induced amnestic deficits: A decade of research.

Authors:  Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2008-10       Impact factor: 1.759

6.  Mental health care bill and electroconvulsive therapy: anesthetic modification.

Authors:  B N Gangadhar
Journal:  Indian J Psychol Med       Date:  2013-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.